1. Home
  2. SSII vs ACHV Comparison

SSII vs ACHV Comparison

Compare SSII & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SS Innovations International Inc.

SSII

SS Innovations International Inc.

N/A

Current Price

$2.61

Market Cap

655.3M

Sector

N/A

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$7.38

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSII
ACHV
Founded
N/A
N/A
Country
India
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
655.3M
726.5M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
SSII
ACHV
Price
$2.61
$7.38
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $14.15
AVG Volume (30 Days)
67.1K
★ 1.3M
Earning Date
10-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 45.45
N/A
EPS
★ N/A
N/A
Revenue
★ $42,484,747.00
N/A
Revenue This Year
$40.29
N/A
Revenue Next Year
$27.85
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 105.74
N/A
52 Week Low
$2.61
$2.62
52 Week High
$10.00
$8.64

Technical Indicators

Market Signals
Indicator
SSII
ACHV
Relative Strength Index (RSI) 26.72 47.22
Support Level N/A $7.01
Resistance Level $4.16 $8.49
Average True Range (ATR) 0.20 0.40
MACD -0.02 -0.07
Stochastic Oscillator 3.29 33.96

Price Performance

Historical Comparison
SSII
ACHV

About SSII SS Innovations International Inc.

SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: